| Mrs Camille Kidd Moses, APN | |
|
2160 S 1st Ave, Maywood, IL 60153-3328 | |
| (708) 216-8591 | |
| (708) 218-8600 |
| Full Name | Mrs Camille Kidd Moses |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Acute Care |
| Location | 2160 S 1st Ave, Maywood, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043843832 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | 209016296 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Camille Kidd Moses, APN 2160 S 1st Ave, Maywood, IL 60153-3328 Ph: (708) 216-9000 | Mrs Camille Kidd Moses, APN 2160 S 1st Ave, Maywood, IL 60153-3328 Ph: (708) 216-8591 |
News Archive
Spectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced four key belinostat data presentations at the 52nd Annual Meeting of the American Society of Hematology (ASH), being held at the Orange County Convention Center in Orlando, Florida, December 4-7, 2010.
If a pregnant mother has a family history of premature birth, she is at risk for a preterm birth of her baby, according to a new study by researchers from Ben-Gurion University of the Negev (BGU) and Soroka University Medical Center.
A novel combination anti-psoriasis therapy has potential for superior and longer-lasting therapeutic effects than current topical treatments by targeting genetic abnormalities in deeper layers of the skin. This research is being presented at the 2013 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in San Antonio, Nov. 10-14.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead product candidate, APF530, for the prevention of acute- and delayed-onset chemotherapy-induced nausea and vomiting (CINV).
› Verified 2 days ago
Dr. Margaret Mary Naber, DNP, APRN, NNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Bldg 101, Room 1752, Maywood, IL 60153 Phone: 708-216-9000 Fax: 708-216-6269 | |
Ms. Victoria Anne Davidson-bell, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-6569 | |
Ijeoma Achebe, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-9000 | |
Lauren M Martin, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-9000 | |
Ms. Emily Wang, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Nancy Pak, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Ems 110, Maywood, IL 60153 Phone: 708-216-9000 |